文献速递中枢神经肿瘤放疗放疗物理与技术

扩散MRI勾画的存活肿瘤体积在放疗中分层预后优于GTV

Diffusion MRI outlined viable tumour volume beats GTV in intra-treatment stratification of outcome.
PubMed 文献 · Radiother Oncol · 2019-12-02

结果显示GTV变化在应答与未应答肿瘤中均下降且速率不可区分,而VTV体积分数仅在应答肿瘤中显著降低,VTV的ADC在应答肿瘤中显著升高、在未应答肿瘤中降低,提示VTV变化可分层治疗结局。

要点

  • 放疗中GTV大小变化不能可靠预测脑转移瘤治疗结局。
  • VTV体积分数变化和VTV的ADC变化可区分应答与未应答肿瘤。
  • 基线肿瘤大小或原发疾病与治疗结局无关联。

核心结论

  • 放疗中GTV大小变化不是脑转移瘤结局的可靠预测指标。
  • VTV体积分数变化和VTV扩散系数变化能够分层治疗结局。

研究设计与样本

  • 放疗前、放疗中及放疗后2-3个月随访时在1 T机器上采集扩散与结构MRI。
  • VTV定义为高b值扩散MRI扫描显示高细胞密度的区域,其扩散系数用ADC表示。
  • 治疗结局用随访T1W MRI的RECIST界值判定,纵向统计分析采用线性混合效应模型。

主要发现

  • GTV在应答和未应答肿瘤中均下降(未应答者下降显著),放疗中下降速率不可区分。
  • VTV体积分数仅在应答肿瘤中显著降低。
  • VTV的ADC在应答转移灶中显著升高,在未应答转移灶中降低。
  • 基线肿瘤大小或原发疾病与结局无关联。

关键数值与推荐

  • VTV定义为高b值扩散MRI扫描显示高细胞密度的区域。
  • 治疗结局采用RECIST界值在随访T1W MRI上判定。

临床怎么用

  • 放疗中可基于扩散MRI勾画VTV并监测其体积分数和ADC变化,以早期预测脑转移瘤治疗应答。
  • 不宜仅依赖放疗中GTV大小变化进行结局判断或治疗调整。

局限性

  • MRI采集使用1 T机器。
  • 随访影像在放疗后2-3个月获取。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: In radiotherapy, treatment response is generally evaluated many weeks after end of the treatment course. If the treatment outcome could be predicted during radiotherapy better tumour control could be achieved through timely adaptation of the treatment strategy. In this study intra-treatment change based on the diffusion MRI outlined viable tumour volume (VTV) was assessed and compared to the standard GTV to study their outcome prediction capacity. MATERIALS AND METHODS: Thirty-eight brain metastases from twenty-one cancer patients were analysed in this prospective trial. Diffusion and structural MRI was acquired on a 1 T machine before, during, and at follow-up 2-3 months after radiotherapy. The VTV was defined as a region with high cellularity using high b-value diffusion MRI scans. Further, the diffusivity of the VTV was derived as the apparent diffusion coefficient (ADC). Treatment outcome was determined using RECIST defined bounds in the T1W MRI follow-up scan. Longitudinal statistical analysis was performed using a linear mixed effect model. RESULTS: The GTV declined in both responding and non-responding (significantly) tumours with inseparable rates during radiotherapy. The VTV volume fraction reduced significantly in the responding tumours only. The ADC of the VTV increased significantly in responding metastases whereas it decreased in non-responding metastases. Furthermore, no association between baseline tumour size or primary disease and outcome was observed. CONCLUSION: GTV size change during radiotherapy is not a reliable predictor of outcome in brain metastases. On the other hand, change in the volume fraction of VTV and diffusivity of VTV shows ability to stratify treatment outcome.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Mahmood F, Hjorth Johannesen H, Geertsen P, et al. Diffusion MRI outlined viable tumour volume beats GTV in intra-treatment stratification of outcome. Radiother Oncol. 2019. PMID: 31805516. doi:10.1016/j.radonc.2019.11.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。